ZURICH Novartis may ratchet up its 2018 sales outlook, its finance chief said on Wednesday, despite halting planned U.S. drug price hikes amid pressure on the industry from President Donald Trump's administration over the high cost of medicines.
- AstraZeneca to stockpile drugs as Brexit 'safety net'
- U.N. says global fight against AIDS is at 'precarious point'
- Bill Gates backs $30 million push for early Alzheimer's diagnostics
- France needs 'food safety police' to avoid new Lactalis crisis: report
- Pfizer-Lilly pain drug meets late-stage trial goals
Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand for its glucose monitoring device for diabetics and gains from its multibillion dollar acquisitions.
LONDON London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.
SOFIA Hundreds of farmers from around Bulgaria rallied in the capital Sofia on Wednesday against the government-ordered mass slaughter of livestock following the first outbreak in the European Union of the highly contagious Peste des Petits Ruminants (PPR).
JERUSALEM Three multinational companies have received an Israeli government grant of 120 million shekels ($33 million) aimed at boosting the presence of large companies and establishing Israel as a hub in biotechnology and medicine.
Video: Health Reform Watch
Shaad Ali's "Soorma" (Warrior), based on hockey player Sandeep Singh's life does one thing right. Its makers picked the right story, one replete with sports movie tropes of highs and lows, triumphs and let-downs.